Number of Shares
79,000.00
Current Holdings Value*
$1.25 Mil
% of Portfolio
8%
Total Estimate Gain
$103,670.00
% of Total Estimate Gain
10.58%

Lion Point Capital, LP's Mineralys Therapeutics Inc Holding Summary

As of 2025-03-31, Lion Point Capital, LP held 79,000.00 shares of Mineralys Therapeutics Inc(MLYS), totaling $1.25 Mil. This investment constitutes 8% of their stock portfolio, and Lion Point Capital, LP now holds 0.12% of the outstanding Mineralys Therapeutics Inc(MLYS) stock.

The initial trade took place in 2024Q1. And since then Lion Point Capital, LP has made 2 purchases of MLYS, at an average price of $12.41, for a total of 79,000.00 shares. Based on historical transaction data and MLYS's current price of $13.72, Lion Point Capital, LP's estimated gain on his MLYS holdings is $103,670.00, reflecting a 10.58% gain to date.

Lion Point Capital, LP MLYS ($13.72) Holding Chart

Lion Point Capital, LP MLYS ($13.72) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1